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Papillomaviruses (PVs) are ancient viruses infecting vertebrates, from fishes
to mammals. Although the genomes of PVs are small and show conserved
synteny, PVs display large genotypic diversity and ample variation in the
phenotypic presentation of the infection. Most PV genomes contain two
small early genes E6 and E7. In a bunch of closely related human papilloma-
viruses (HPVs), the E6 and E7 proteins provide the viruses with oncogenic
potential. The recent discoveries of PVs without E6 and E7 in different fish
species place a new root on the PV tree, and suggest that ancestral PVs con-
sisted of the minimal PV backbone E1-E2-L2-L1. Bayesian phylogenetic
analyses date the most recent common ancestor of the PV backbone to
424 million years ago (Ma). Common ancestry tests on extant E6 and E7
genes indicate that they share a common ancestor dating back to at least
184 Ma. In AlphaPVs infecting Old World monkeys and apes, the appearance
of the E5 oncogene 53–58 Ma concurred with (i) a significant increase in sub-
stitution rate, (ii) a basal radiation and (iii) key gain of functions in E6 and
E7. This series of events was instrumental to construct the extant phenotype
of oncogenic HPVs. Our results assemble the current knowledge on
PV diversity and present an ancient evolutionary timeline punctuated by
evolutionary innovations in the history of this successful viral family.
This article is part of the theme issue ‘Silent cancer agents: multi-
disciplinary modelling of human DNA oncoviruses’.1. Background
Papillomaviruses (PVs) present a small, circular double-stranded DNA genome
with an average size of 8 kbp. A canonical PV genome is organized into three
major regions: an upstream regulatory region (URR), an early gene region encod-
ing for three to six proteins (E6, E7, E5, E1, E2 and E4, nested in E2), and a late gene
region encoding for two capsid proteins (L2 and L1) [1]. Proteins in the early region
are (among other functions) involved in viral replication and cell transformation,
while the capsid proteins self assemble to yield virions and encapsidate the
genome. Some of the early genes are dispensable, and the minimal PV genome
may contain an URR together with the E1-E2-L2-L1 genes.
Most PVs are part and parcel of a healthy skin microbiota causing asympto-
matic infections in skin and mucosa. In humans, the best studied host, certain
human papillomaviruses (HPVs) may cause benign lesions, such as skin and gen-
ital warts, where the transmission of genital warts occurs primarily via sexual
activity [2]. Only a limited number of evolutionary related HPVs are associated
with malignant lesions, which can develop into cancer [3,4]. Oncogenic HPVs
are a major public health concern as they are responsible for virtually all cases
of cervical (99%) and most cases of anal cancer (88%), as well as for a fraction
of cancers on the vagina (78%), penis (51%), oropharynx (13–60%, depending
on the geographical region) and vulva (15–48%, depending on age) [5]. In onco-
genic HPVs, the E5, E6 and E7 proteins are directly involved in the onset of cancer.
Specific cellular activities of these genes are linked to the virus oncogenic potential
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2and PVs that do not contain these genes are not associated with
cancer. In oncogenic PVs, E6 is able to induce degradation of
the p53 tumour suppressor protein [6–8], while the E7 protein
degrades members of the retinoblastoma protein (pRb) family
[9], which also act as tumour suppressors. The E5 protein in
oncogenic PVs is involved in evasion of the immune response
and decreases the cellular dependence on external growth
factors, thus inducing cell proliferation [10].
PVs were first isolated in mammals, but were later also found
to infect birds, turtles, snakes and fish. The first fish PV was
recently discovered in skin lesions in a bony fish and named
after its host Sparus aurata papillomavirus 1 (SaurPV1) [11]. The
SaurPV1 genome exhibits a unique organization—to date, it
is the only PV that consists of the minimal PV backbone.
Moreover, the nucleotide sequences of SaurPV1 are so divergent
that its discovery led to the recent proposal of reorganizing
the Papillomaviridae taxonomy into two subfamilies: Firstpapillo-
mavirinae, containing 52 genera, and Secondpapillomavirinae,
containing one new genus to which SaurPV1 belongs.
PVs have evolved in close relationship with their hosts,
which allows phylogenetic inference based on host fossil
records. However, PV diversity cannot be explained by
virus–host codivergence alone. As shown in previous studies
[12,13], distantly related PVs infect the same host species,
suggesting independent codivergence between viruses within
clades and their hosts. The growing number of animal PV
sequences available in the online databases allow us to add
pieces to the puzzle on the origin and evolution of PV genes
and genomes. The modular structure of the PV genome and
the genome organization of PVs infecting fish reinforce the pro-
posed evolutionary scenario of an ancestral PV that did not
contain any of the E5, E6 or E7 genes, which would have
been subsequently acquired during PV evolution [14].
To better understand how certain HPVs became oncogenic,
we have set up a global dating study to look into the evolution-
ary history of the PV genes and genomes. We have payed
special attention to the origin of the PV oncogenes, assessing
whether they are monophyletic or have instead originated in
several convergent acquisition/loss events. We further look
into the roles of these genes and how these novel functions
relate to the emergence of oncogenic potential. This paper,
combining novel data with the previous literature, aims to
provide insight into the evolution of PVs on a dated scale.2. Material and methods
(a) Data collection and alignments
We downloaded 354 full-length PV genome sequences (154 animal
and 200 human) from the PaVE (pave.niaid.nih.gov, [15]) and
GenBank (https://www.ncbi.nlm.nih.gov/genbank/) databases
(electronic supplementary material, table S1). The previously ident-
ified recombinant PVs isolated from cetaceans (PphoPV1-2,
TtruPV1-7, DdelPV1, PspiPV1) [16–18] were removed from the
dataset, leaving us with a dataset of 343 full length PV genomes.
The E6, E7, E1, E2, E5, L2 and L1 genes were extracted and aligned
individually at the amino acid level using MAFFT v.7.271 [19],
corrected manually and backtranslated to nucleotides using
PAL2NAL v.14 [20]. The alignment was filtered using Gblocks
v.0.91b [21], such that uninformative positions were removed. For
E1, E2, L2 and L1 the original alignments contained 3516, 4014,
5070 and 2610 nucleotide positions, respectively. After Gblocks
filtering these alignments contained 1665, 864, 933 and 1398 pos-
itions, respectively. For tree construction, the E1, E2, L2 and L1were concatenated using a custom perl script. The E6, E7 and E5
oncogenes were tested for presence/absence in the dataset. The
size of these genes was calculated for each PV, and in some cases,
the annotation was manually corrected before alignment.
(b) Phylogenetic analyses and dating
For the concatenated E1-E2-L2-L1 alignment a maximum-likelihood
(ML) tree was constructed at the nucleotide level, using RAxML
v.8.2.9, under the GTRþG4 model, using 12 partitions (three for
each gene, corresponding to each codon position) and 1000 boot-
strap replicates (electronic supplementary material, figure S1A).
The tree was rooted using the SaurPV1 sequence. Based on the
best-sampled ML tree, 18 calibration points were selected on sub-
trees where the E1-E2 and L2-L1 trees did not show discrepancies
and where the host tree matched the PV tree. Calibration point esti-
mates were based on host fossil records from TimeTree (http://
www.timetree.org/). The effect of the calibration points, and there-
with forced clades, on the topology of the tree was validated
by constructing an ML tree constrained to the calibrations used
(electronic supplementary material, figure S1B) and subsequent
comparison to the unconstrained tree using a Shimodaira–
Hasegawa test [22], as implemented in RAxML. The constrained
tree (likelihood: 2977756.687001) was not significantly worse
than the unconstrained tree (likelihood: 2977683.344298) at the
2% significance level (DLH: 273.342703; s.d.: 32.00218).
Bayesian time inference was performed at the nucleotide
level using BEAST v.1.8.3 [23], under the GTRþG4 model, using
12 partitions, the uncorrelated relaxed clock model [24] with a log-
normal distribution and a continuous quantile parameterization
[25] and the Yule Speciation Process tree prior [26,27]. The con-
strained ML tree was used as starting tree for time inference.
Two independent MCMC chains were run for a maximum of 109
generations and combined when convergence was reached.
Chain #1 consisted of 5.249  108 states with an effective sample
size (ESS) of 1464, 419 and 4169 for the posterior, prior and likeli-
hood, respectively. Chain #2 consisted of 5.265  108 states with an
ESS of 1227, 360 and 3110 for the posterior, prior and likelihood,
respectively. An uncollapsed version of the tree figure with the
two chains combined can be found in electronic supplementary
material, figure S2.
(c) Common ancestry test for the E6 and E7 oncogenes
To test whether the extant E6 and E7 genes have a single
common ancestor, we used the software Bali-Phy [28]. In this
approach, the input data are the unaligned sequences, where
the alignment is one of the parameters to be treated as an
unknown random variable [29]. We ran our analysis on two
different reduced datasets (indicated in electronic supplementary
material, table S1), containing representative species from the
different PV clades in figure 1. Each reduced dataset contained
35 sequences representing the different PV crown groups, includ-
ing the seven PVs infecting Aves and Testudines (grey clade), six
Alpha-Omikron PVs (red clade), six Beta–Xi PVs (green clade),
six Lambda–Mu PVs (yellow clade), six Delta–Zeta PVs (blue
clade) and the four PVs infecting manatees (black clade). For
each dataset, we ran the analysis for E6 and E7, both separately
and concatenated. We assumed the null hypothesis (H0) of
Common Ancestry (CA). The Bali-Phy analyses were performed
at the amino acid level using the LG substitution model. The like-
lihood for the CA model was obtained running the software
for all the E6 and/or E7 sequences together. For the different
Independent Origin (IO) models, we ran the analysis for each
group independently. For each IO model (H1–H7), the likeli-
hood is represented by the sum of the likelihoods obtained for
the different groups within that model. We only considered IO
scenarios that were biologically plausible based on the PV tree
(figure 1). For each model, three independent MCMC chains
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Figure 1. Dated Bayesian phylogenetic tree for a dataset containing 343 PVs. The tree was constructed at the nucleotide level based on the concatenated E1-E2-L2-
L1 genes. The scale bar is given in million years ago (Ma). Values at the nodes correspond to posterior probabilities, where asterisks indicate full support. Error bars
encompass 95% highest posterior density for the age of the nodes. Clock symbols indicate the nodes used for calibration. Clades are coloured according to the PV
crown group classification, as indicated in the legend on the left. Next to the tree on the right, the taxonomic group (superorder, class, order, parvorder, no rank)
corresponds to the one in which the host clades could best be summarized. Below the tree, a geological time scale is drawn. The matrix next to the taxonomic host
groups indicates the presence/absence of the E6, E7 and E5 genes for each PV (see legend), and the classification of E5 (a, b, g, d, e , z) is indicated within the
matrix. Next to the matrix, the size of the oncogenes is plotted. (Online version in colour.)
royalsocietypublishing.org/journal/rstb
Phil.Trans.R.Soc.B
374:20180303
3
were run for 100 000 iterations. The three runs were combined
and checked for convergence. Subsequently, the marginal
likelihood was calculated over the three runs using the stabilized
harmonic mean estimator. The Bayes factor (BF) for CA is
then DBF ¼ log[Prob(CA)] 2 log[Prob(IO)], such that positive
values favour CA and negative values indicate IO. As a control,
we conducted the same analyses on the E1 genes, which are
monophyletic (electronic supplementary material, table S2).
To support the results of the Bali-Phy analyses, we performed a
random permutation test as described in de Oliveira Martins &
Posada [30]. In this test, the sequences for one of the groups are ran-
domly shuffled and statistics are recalculated after realignment
with MUSCLE [31], which tells us how much the original data
depart from those with phylogenetic structure partially removed.
The statistics used in this test are ML tree lengths and log likeli-
hoods, calculated with PhyMLv3.0 [32]. We reshuffled one of the
groups 100 times, each time realigning against the other groups
in the dataset. For each iteration, the alignment is always optimized
and to make the statistics comparable, the same alignment is used
for both the IO and CA hypotheses.(d) Statistics and graphics
Statistical analyses and graphics were done using R [33], with the
aid of the packages ‘ape’, ‘car’, ‘ggplot2’, ‘ggtree’, ‘stats’, ‘strap’,‘pgirmess’ and ‘reshape2’. The final display of the graphics was
designed using Inkscape v.0.92 (https://inkscape.org/en/).3. Results and discussion
(a) Papillomavirus evolution: old ancestry, primary
radiation and secondary diversification
Although the number of animal PV sequences in databases is
growing, the number of available non-mammalian sequences
remains low. At the start of this study, there were five avian,
two turtle, one python and one fish PV genome sequences
available in GenBank. This fish PV was recovered from lesions
in the bony fish gilthead seabream (Sparus aurata) (SaurPV1)
[11]. The genome of SaurPV1 is significantly smaller (5748
kbp) than most previously described PVs (around 8 kbp),
and is unique as it is the only PV that contains the minimal
PV backbone E1-E2-L2-L1 while lacking any of the oncogenes
(E5, E6 and E7). This particular genome structure of PVs infect-
ing fish has been confirmed by metagenomic assembly of PVs
in other fish host species enriched for circular DNA viruses
(GenBank accessions: MH510267, MH616908, MH617143,
Table 1. Inferred node age in million years ago (Ma) for the most recent
common ancestors (MRCA) of the different PV clades and for the root
of the tree. The rows of the PV crown groups are named accordingly
(figure 1), otherwise the taxonomic host group is given. An asterisk
indicates the presence of one exception within the clade of PVs infecting
mammals, which is a python PV (discussed in the text). The differences
between the ancestral node ages of the crown groups as well as the root
are significant after performing a Kruskal – Wallis rank sum test (chi-sq. ¼
51993, d.f. ¼ 5, p , 2.2  10216) and a multiple comparison test after
Kruskal – Wallis (electronic supplementary material, table S3). Although the
inferred times and the posterior distributions for the ancestral Alpha –
Omikron and Delta – Zeta as well as the Beta – Xi and Lambda – Mu clades
are similar (electronic supplementary material, figure S3), the significant
difference between these groups was confirmed by a Wilcoxon rank
sum test (W ¼ 57 451 000, p , 2.2  10 2 16 and W ¼ 50 158 000,
p , 2.2  1016, respectively).
PV clade MRCA age (Ma) 95% HPD
root 424 402 – 446
amniotes 184 161 – 208
Aves/Testudines (grey) 171 148 – 195
mammals* 121 112 – 132
Lambda – Mu (yellow) 95 90 – 100
Beta – Xi (green) 94 88 – 100
Delta – Zeta (blue) 84 79 – 90
Alpha – Omikron (red) 83 76 – 90
Sirenia (black) 77 68 – 87
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4MH617579), which were made available during redaction of
this manuscript. Besides the unique genome organization of
these PVs, the distant sequence relatedness to other PVs
suggests a new root on the tree (Spariformes in figure 1). A
recent study dated this root to 481 Ma, albeit with a broad high-
est posterior density (HPD) interval (95% HPD: 326–656) [34].
In our study, the root of the tree was dated back to 424 Ma (95%
HPD: 402–446) (figure 1), which is just before the Devonian
period (also often named ‘Age of Fish’). These results indicate
that PVs have an old ancestry: the ancestral anamniotes were
already infected by ancestral PVs in the Palaeozoic, and more
specifically in the Silurian period, when bony fish appeared.
Millions of years later, in the Mesozoic, we find the last
common ancestor of PVs infecting amniotes at around 184
Ma (95% HPD: 161–208), followed by a split of PVs infecting
birds (Aves) and turtles (Testudines) (grey clade in figure 1)
and PVs infecting mammals (all other PVs with one exception,
described below).
The period between the last common ancestor of amniotes
and the last common ancestor of mammals corresponds to the
evolution of the main traits and skin structures exclusive to
mammals, namely hairs, sweat glands, sebaceous glands and
milk glands. It has been proposed that the modifications in
the proto-mammalian skin environment increased the avail-
ability of novel cellular targets for PVs [1], so that adaptation
to these new niches led to a primary radiation within PVs. A
secondary diversification of PVs infecting mammals started
around 120 Ma, and the radiation that generated the different
PV crown groups dates back to between 106 Ma and 83 Ma,
which fits well within the time of crown radiation of placental
mammals (figure 1) [35]. Most PVs infecting mammals have
been classified into four different crown groups: Delta–Zeta,
Lambda–Mu, Alpha-Omikron and Beta–Xi (figure 1). PV
crown groups are named after the two most distantly related
species therein enclosed [13]. The inferred age for the ancestors
of the different PV crown groups is significantly younger
than the root age, and significantly different between groups
(table 1). This secondary diversification event corresponds to
the independent co-divergence between viruses and their
hosts within each of the major viruses–host clades, generating
the enormous diversity of PVs we observe today. Most of these
PVs are associated with asymptomatic infections, while some
of them cause productive infections, and only a few display
carcinogenic potential.
(b) Inconsistencies of the current scenario of
papillomaviruses evolution
The proposed scenario of a biphasic evolution of PVs, that is to
say a primary radiation event followed by a secondary diversi-
fication, fits well globally with prior phylogenetic analyses
[1,13,14], as well as with those that we present here. Neverthe-
less, we observe a number of flaws and anomalies in the PV
trees that cannot be explained with our current, linear under-
standing of PV evolution. Most often, inconsistencies can be
imputed to the non-systematic viral sampling, hitherto largely
based on economic or leisure interests of the host species, as
well as on opportunistic sampling by a reduced circle of
wildlife disease scientists. Generally, a comprehensive under-
standing of PV evolution needs to integrate additional
evolutionary mechanisms, such as lineage sorting and host
switch [13], which may radically change the relationship
between a viral lineage and its host species.The first anomaly is weak consistency in time inference in
the deep nodes of the PV tree, as the inferred age of the
MRCA of PVs infecting amniotes (184 Ma, table 1) is more
recent than the estimated divergence time between Mammalia
and Sauropsida–the two main amniote lines–, which is
around 312 Ma (CI: 297–326; estimate derived from 22 studies
at http://www.timetree.org/). We did not force any timing
interval for this node in our calibrations, so this result of a
‘younger-than-expected’ node most likely reflects the lack of
sufficient phylogenetic information around it, with a long
branch connecting it to the root. We will need to increase our
sample size for mainly PVs infecting sauropsids and bony
fish to obtain a more accurate time estimate for the MRCA of
PVs infecting amniotes.
The second, conspicuous, anomaly is the presence of a PV
infecting a carpet python, Morelia spilota papillomavirus 1
(MspiPV1), well nested within mammalian PVs (Squamata
in figure 1). The viral genome was retrieved from histologi-
cally determined papilloma-like neoplasias in one python,
that tested negative for herpesvirus infections [36]. This PV
infecting squamates is not a lone exception, as during the
writing of this manuscript, the genome of a Boa constrictor
papillomavirus (BconPV1) was made available (GenBank
accession: MH605022). A standard protein BLAST [37] ident-
ified E1 and L1 of the boa PV as the best hits to the python PV
with 58% and 69% of identity, respectively. We have further
confirmed that the boa and python PVs are indeed sister taxa
in a newly built E1-E2-L2-L1 tree (electronic supplementary
material, figure S4). This clustering supports the phylogenetic
position of these two PVs infecting squamates to be close to
royalsocietypublishing.org/journal/rstb
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5the unresolved crown of mammalian PV crown groups. The
lineages of boas and pythons split only 74 Ma (http://www.
timetree.org/) and if this timing applies to the corresponding
viruses, their MRCA would also fit well in the secondary diver-
sification of PVs. Overall histological assessment of MspiPV1 in
papillomatous lesions and mostly the finding of BconPV1
strongly suggest that there exists a genuine group of PVs infect-
ing squamates that clusters with mammalian PVs rather than
with PVs infecting birds and turtles. We propose that this
lineage emerged after a host switch of an ancestral mammalian
PV. Most likely, the evolutionary changes during the second-
ary PV radiation may have facilitated colonization of this
new ancestral squamate host.
The third anomaly of a solitary PV branching off incon-
sistently with host phylogeny is a PV genome isolated from
a brush-tailed bettong (Bettongia penicillata papillomavirus 1;
BpenPV1), a rare marsupial [38]. This is the only full-
genome report of PVs in marsupials, although fragmentary
evidence for PVs infecting marsupials and monotremes has
been communicated [39]. We report here BpenPV1 (Diproto-
dontia in figure 1) to be well nested within the Beta–Xi crown
group, sharing a common ancestor 80 Ma (95% HPD: 70–89)
with a European hedgehog PV (EeurPV1; host Insectivora in
figure 1), also solitary in this crown group. Since all other PVs
in this crown group have been retrieved from Laurasiatheria,
we interpret that a host switch from a PV infecting placental
mammals towards marsupials occurred after the emergence
of the Beta–Xi crown group, generating this lineage. A sys-
tematic screening for PVs in marsupials and monotremes is
seriously needed, aiming to populate the viral tree in this
important clade of non-placental mammal hosts.
Finally, the fourth anomaly in the PV tree is the poor resol-
ution around the crown of mammalian PVs. Should the null
hypothesis of virus–host co-diversification be true, for placen-
tal mammals one would expect PVs infecting Xenarthra and
Afrotheria to be basal to PVs infecting Euarchontoglires and
Laurasiatheria. However, no PV infecting Xenarthrans has
been so far identified, and within Afrotherians only a few
PVs infecting manatees (black, Sirenia clade in figure 1) have
been reported. These manatee PVs are clearly monophyletic,
with an ancestor dating back to 77 Ma (95% HPD: 68–87).
Although their position within the crown of PVs infecting
placental mammals is not well resolved, they are definitely
not basal to all PVs infecting Laurasiatherians and Euarchonto-
glires. Indeed, the MRCA of PVs infecting placental mammals
dates back to 121 Ma (95% HPD: 112–132), and the most basal
PV is consistently a fruit bat PV (Rosettus aegyptiacus PV1,
RaegPV1) [40]. This virus does not cluster with any other bat
PV included in this study, which actually are rather dispersed
over the tree [41,42]. Once again, we interpret that the lack
of appropriate host sampling prevents resolution of the
mammalian PV crown.(c) The extant E6 and E7 oncogenes have a common
ancestor, but extant E5 oncogenes are not
monophyletic
We have recently shown that extant E5 oncogenes do not have a
common ancestor [43]. This is not surprising as E5 proteins
are only present in a few PV clades (figure 1), and are highly
divergent. On the contrary, both the E6 and E7 oncogenes are
present in most PV genomes, and are less divergent than E5oncogenes [3]. Interestingly, some PVs lack either E6 or E7
(the presence/absence matrix in figure 1). A group of PVs lack-
ing E7 (MricPV1, PphoPV4, SscrPV1, UmarPV1) infect
laurasiatherian hosts and belong to the Alpha–Omikron PV
crown group. All other members of this crown group infect
Primates and present both E6 and E7. On the other hand,
PVs lacking E6 are more disperse along the tree and belong
to different crown groups: one parrot (PeriPV1) PV in the
grey clade, one donkey PV (EasiPV1) in the Delta–Zeta
crown group, and eight bovine PVs (BPV3, BPV4, BPV6,
BPV9, BPV10, BPV11, BPV12, BPV15) and three HPVs
(HPV101, HPV103, HPV108) in the Beta–Xi crown group.
Regarding the size of the oncogenes (indicated next to the
tree in figure 1), E6 is small (median: 253.5 nt; Q1: 249.0 – Q3:
258.0) in the genomes of PVs infecting birds and turtles
(grey clade), while it is of double size (median: 438.0 nt;
Q1: 420.0 – Q3: 462.0) in the genomes of all PVs infecting
mammals. This increase in size correlates with the presence
of a second E6 zinc-binding motif domain [44], which
could have appeared after duplication of the first original
motif and transformed the original homodimer into an
internal dimer [45].
As described above, during the production of this manu-
script four novel fish PV genomes became available at the
GenBank database, infecting three new bony fish species (one
in the rainbow trout, one in the red snapper and two in the had-
dock). None of the genomes of these novel fish PVs contains
any of the oncogenes. For the now five fish PVs, the most
conserved E1 and L1 genes present a high sequence diversity.
To see whether the novel fish PVs cluster together with the
ancestral SaurPV1, we recalculated our ML tree based on
the concatenated E1-E2-L2-L1 sequences. Indeed, we found
that all fish PVs are monophyletic (electronic supplementary
material, figure S4).
The pattern of presence/absence of E6 and E7 in extant PVs
demands an evolutionary explanation. One scenario would
propose that the MRCA of all PVs already contained these
ORFs and invokes six independent repeated loss events for
E6 in different PV lineages [46], including in the lineage leading
to extant fish PVs, and one gene loss event for E7 in another PV
lineage. An alternative scenario, more parsimonious with the
absence of E6 and E7 in fish PVs, would postulate an ancestral
PV genome spanning only the minimal arrangement E1-E2-L2-
L1, the gain of the ancestral E6 and E7 genes in the lineage of
amniote PVs, at least 184 Ma, followed by five independent
loss events for E6 and one loss event for E7.
To unravel a piece of the evolutionary history of E6 and E7,
we performed CA tests as described in de Oliveira Martins &
Posada [29] using the program Bali-Phy [28]. The power of
this approach is that the alignment and the phylogeny are esti-
mated at the same time, reducing the bias towards supporting
CA introduced by the alignment step. We ran our analyses on
two reduced datasets containing representatives from each PV
clade. We tested different hypotheses supporting either CA or
IO for E6 and E7 separately as well as concatenated. We only
considered IO scenarios that were biologically plausible
based on the PV tree, leading us to eight different hypotheses
(H0–H7), as displayed in tables 2 and 3. We assumed CA as
the null hypothesis (H0; Material and methods). For the IO
scenarios (H1–H7), we performed the analysis separately for
each group, where the sum of the marginal likelihood of
these groups represents that of the hypothesis tested. As an
example, for H2, we ran one analysis for the Aves/Testudines
Table 2. Testing for common ancestry of E6 and E7 on reduced dataset 1. The test was performed using the software Bali-Phy on the concatenated E6 and E7
amino acid sequences as well as on E6 and E7 separately. The log marginal likelihoods (P(datajM)) are indicated for the Common Ancestry (CA) model (H0) and
the alternative Independent Origin (IO) models (H1 – H7). The Bayes factor for CA is calculated as DBF ¼ log [Prob(CA)] 2 log [Prob(IO)], such that positive
values favour CA and negative values indicate IO.
E6E7 E6 E7
model P(datajM) DBF P(datajM) DBF P(datajM) DBF
H0: (grey-blue-yellow-red-black-green) 219083.055 0 210960.151 0 28239.297 0
H1: greyþ(blue-yellow-red-black-green) 219425.259 342.204 211008.514 48.363 28300.605 61.308
H2: greyþblueþ(yellow-red-black-green) 219595.075 512.020 211102.586 142.435 28391.373 152.076
H3: greyþblueþyellowþ(red-black-green) 219883.098 800.043 211266.682 306.531 28515.244 275.947
H4: greyþblueþyellowþredþ(black-green) 220108.285 1025.230 211390.535 430.384 28644.525 405.228
H5: greyþblueþ(red-black)þ(green-yellow) 219850.013 766.958 211239.646 279.495 28541.050 301.753
H6: greyþblueþredþblackþ(green-yellow) 222355.489 3272.434 211352.869 392.718 28638.945 399.648
H7: greyþblueþyellowþredþblackþgreen 220317.714 1234.659 211503.409 543.258 28748.908 509.611
Table 3. Testing for common ancestry of E6 and E7 on reduced dataset 2. The test was performed using the software Bali-Phy on the concatenated E6 and E7
amino acid sequences as well as on E6 and E7 separately. The log marginal likelihoods (P(datajM)) are indicated for the Common Ancestry (CA) model (H0) and
the alternative Independent Origin (IO) models (H1 – H7). The Bayes factor for CA is calculated as DBF ¼ log [Prob(CA)] 2 log [Prob(IO)], such that positive
values favour CA and negative values indicate IO.
E6E7 E6 E7
model P(datajM) DBF P(datajM) DBF P(datajM) DBF
H0: (grey-blue-yellow-red-black-green) 219083.055 0 210847.336 0 28106.947 0
H1: greyþ(blue-yellow-red-black-green) 219165.438 82.383 210915.029 67.693 28153.371 46.424
H2: greyþblueþ(yellow-red-black-green) 219406.063 323.008 211020.832 173.496 28281.371 174.424
H3: greyþblueþyellowþ(red-black-green) 219676.573 593.518 211174.707 327.371 28424.371 317.424
H4: greyþblueþyellowþredþ(black-green) 219921.623 838.568 211306.744 459.408 28539.261 432.314
H5: greyþblueþ(red-black)þ(green-yellow) 219682.881 599.826 213601.982 2754.646 28411.536 304.589
H6: greyþblueþredþblackþ(green-yellow) 219886.211 803.156 213704.295 2856.959 28511.299 404.352
H7: greyþblueþyellowþredþblackþgreen 220121.000 1037.945 211412.956 565.620 28642.184 535.237
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clade (grey), one analysis for the Delta–Zeta crown group (blue
clade), and one analysis for the Lambda–Mu crown group
(yellow clade), Alpha–Omikron crown group (red clade),
Sirenia clade (black) and Beta–Xi crown group (green clade)
together. Therefore, we obtained three log marginal likelihood
estimates, and the sum of these rendered the likelihood for H2.
Then we calculated the BF as DBF ¼ log [Prob(CA)] 2 log
[Prob(IO)], such that positive values favour CA and negative
values indicate IO. The overall results suggest (tables 2 and
3) that extant E6 and E7 share a common ancestor, indepen-
dently of whether the analyses were performed on the
concatenated E6-E7, or on E6 and E7 alone. Although conver-
gence was reached between the three independent MCMC
runs for all groups within the hypotheses tested, we performed
an additional permutation test to further validate CA as the
preferred scenario. This test was performed as described in
de Oliveira Martins & Posada [30], where the columns of the
alignment for one of the groups are randomly shuffled, such
that the alignment is preserved within the group but disrupted
between groups. After shuffling, the alignment is always
optimized for the original dataset, so that the ML tree can beestimated and summary statistics can be calculated (see
Material and methods). The results of the permutation test
support the hypothesis of CA as the most likely scenario
(electronic supplementary material, file S1). Nevertheless, this
test also reveals that the second-best supported model—H1:
IO for E6 and E7 in the Aves/Testudines clade—is not signifi-
cantly worse. Thus, although the best-supported scenario is
common origin for all extant E6 and E7 genes, we cannot
reject the hypothesis that E6 and E7 in extant PVs infecting
birds and turtles have originated independently from the
E6 and E7 genes in extant PVs infecting mammals. Only a
denser sampling of PV genomes from different large amniote
clades outside mammals, as well as from monotremes
and marsupials, may allow us to distinguish between these
conflicting hypotheses.
(d) The emergence of an oncogenic potential in certain
human papillomaviruses
A well-substantiated body of scientific literature suggests that
the oncogenic potential of certain HPVs lies in the perturbation
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Figure 2. This tree is a zoom in on the Alpha – Omikron PV crown-group shown in figure 1. Values at the nodes correspond to posterior probabilities, where
asterisks indicate full support. Error bars encompass 95% highest posterior density for the age of the nodes; next to the error bars, the median node age is
given in millions of years ago (Ma). Clock symbols indicate the nodes used for calibration. A black arrow indicates the timing for the emergence of E5 gene
in the ancestral PV genome, between 53 and 58 Ma. Boxes display the average evolutionary rate for the complete PV tree (in grey) or for the AlphaPV subtree
after the emergence of E5 (in black). On the right side of the tree, the different PV species, the clinical presentation and host taxonomy are given. Dots label HPVs
that have been classified by the IARC as carcinogenic to humans (black dots, group I) or probably/possibly carcinogenic to humans (grey dots, groups IIa and IIb).
The three barplots on the right represent: (a) the worldwide prevalence of each HPV in women with normal cervical cytology, with error bars indicating the 95%
confidence interval; (b) the oncogenic potential for each HPV, proxyed as the ratio between the prevalence of each HPV in cervical cancers divided by the prevalence
in normal cervical cytology), with error bars indicating the 95% confidence interval; (c) the E6-mediated p53 degradation activity, expressed as the inverse value of
the EC50 in ng of E6 protein needed to degrade cellular p53, with higher values indicating an enhanced potential of E6 to degrade p53; error bars indicate an
approximate of the standard error of the mean. The first two barplots contain data obtained from the ICO/IARC HPV Information Centre (http://www.hpvcentre.net/),
while the third contains data obtained from Mesplede et al. [7]. The correlation analysis for the second and third barplot is shown in the inset at the bottom. For
the raw data of the barplots, see electronic supplementary material, table S4. (Online version in colour.)
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of key cellular checkpoints by the E6 and E7 proteins. However,
although most PVs contain these genes, only a few of them are
actually associated with cancer. Among the more than 220
HPVs, around 20 closely related AlphaPVs have been classified
by the International Agency for the Research on Cancer (IARC)
as carcinogenic or potentially carcinogenic to humans. Apart
from humans, most other cancer cases associated with PVs
are rare: EcabPV2 in penile cancers in stallions [47], RaegPV1in basosquamous carcinoma in the Egyptian fruit bat [40] or
RrupPV1 in a nasolabial tumour in a free-raning chamois
[48]. A more specific rare case is represented by bovine PVs
(BPVs). These PVs induce benign tumours of cutaneous or
mucosal epithelia in the cattle; however, in the case of BPV1
(and less common BPV2), a host switch reveals its oncogenic
potential, as in horses BPV1 can give rise to malign fibroblastic
tumours (sarcoids) [49]. The later classified BPV13 has also
royalsocietypublishing.org/journal/rstb
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8been found in equine sarcoids [50]. Nevertheless, BPV1 is also
detected in the skin and blood of healthy horses [51,52], and
one report suggests that equine-adapted BPV1 strains exist
[52,53]. It has been proposed that BPV1 variant sequences are
associated with either a benign or malign phenotype by altering
the expression of the E5 protein [54]. Besides this host switch
from a bovine PV to an equine host, eight different equine
PVs have been described (PaVE: pave.niaid.nih.gov, [15]).
Equine papillomavirus 2 (EcabPV2) has been detected in genital
squamous cell carcinomas (SCCs) and healthy genital mucosa
[55,56]. However, odd ratios for the presence of viral material
in diseased versus healthy animals indeed suggests that
EcabPV2 contributes to the onset and progression of genital
SCCs in horses [55,57]. Preliminary findings further suggest
that EcabPV2 resides in infected cells as virions, viral episomes
and integrated viral DNA [56], similar to cancer-associated
HPVs [58]. This seems to be an example of convergent evol-
ution, where EcabPV2 and oncogenic HPVs both evolved
analogous mechanisms independently to stimulate the
development of PV-associated cancers.
Within the clade of PVs infecting primates (AlphaPVs:
Catarrhini in red clade in figure 1), the E5 proteins are classified
into different groups (E5a, E5b, E5g, E5d, E5e, E5z) according
to their hydrophobic profiles and phylogeny [3]. The AlphaPVs
divide in three subclades with three different clinical presenta-
tions: cutaneous warts, genital warts and mucosal lesions
(figure 2). The presence of a given E5 type strongly correlates
with the clinical presentation of the corresponding PV infec-
tion: E5a is associated with malignant mucosal lesions, E5b
is associated with benign cutaneous lesions, and the two puta-
tive proteins E5g and E5d are associated with benign mucosal
lesions [3]. The appearance of the E5 proto-oncogene in the
ancestral AlphaPV genome can be dated back to between 53
and 58 Ma (figure 2), and concurred with an event that was
instrumental for the differential oncogenic potential of pre-
sent-day HPVs. One hypothesis is that the appearance of E5
triggered an adaptive radiation that generated the three viral
lineages with different clinical manifestations [1]. Nevertheless,
we have recently shown that not all E5s have a common ances-
tor [43]. We interpret that E5s evolved de novo out of an initially
non-coding region that integrated between the early and
the late genes in the genome of an ancestral AlphaPV lineage.
Interestingly, at the time of the integration of this non-coding
region, we observe an acceleration of the evolutionary rate
in the corresponding branch, two times higher than the
overall PV substitution rate (figure 2). These results suggest
the accommodation of the E5s in this region and the promotion
of an adaptive radiation, where certain E6 (and probably also
E7) proteins acquired the ability to degrade tumour suppressor
proteins and facilitate the development of cancer in different
tissues.
The oncogenic potential of HPVs strongly matches viral
phylogeny [3,4]. The potential of p53 degradation by E6 proteins
from AlphaPVs is highly correlated with such a phylogenetic
grouping [6], which has suggested a mechanistic basis for the
connection between phylogeny and oncogenicity. Although
E6-mediated p53 degradation has always been considered
one of the hallmarks of HPV-mediated cervical cancer [59],
the connection between molecular mechanism and infec-
tion phenotype remains unclear. First, E6 proteins from
non-oncogenic HPVs, notably HPV71, can also induce p53
degradation [6]. Second, rare albeit well-documented cases
exist of malignancy associated with non-oncogenic HPVs,whose E6 proteins do not degrade p53 [60]. Finally, third,
when the E6-mediated p53 degradation activity has been
finely quantified [7], a more complex picture is revealed. Our
thought-provoking results displayed in figure 2 clearly show
that there is no correlation between the oncogenic potential for
HPVs in cervical cancer, and the E6-mediated p53 degradation
activity (Pearson’s product-moment correlation ¼20.0303016,
t ¼ 20.14852, d.f. ¼ 24, p ¼ 0.8832). Cogent examples are
HPV16 and HPV18, which display the highest oncogenic poten-
tial (proxyed as the ratio between worldwide prevalence in
cervical cancers and worldwide prevalence in women with
normal cervical cytology; data obtained from the ICO/IARC
HPV Information Centre), but whose corresponding E6 proteins
are not especially efficient at inducing p53 degradation (prox-
yed as the inverse of the EC50 concentration of E6 needed to
degrade 50% of the cellular p53 protein, data obtained from
[7]). For comparison, E6 from HPV58 requires 17-times less
concentration to achieve the same p53 degradation effect as
E6 from the closely related HPV16, and E6 from
HPV59 requires 53-times less concentration to achieve as
much p53 degradation as E6 from the closely related HPV18.
Other factors, such as mRNA splicing and the presence of
particular spliced E6 isoforms specific to oncogenic HPVs [61],
may play essential roles in defining the overall oncogenic
potential of the different HPVs.4. Conclusion
In this study, we have revisited the evolution of PVs using
phylogenetic dating on the largest and most diverse dataset
compiled to date. The evolutionary scenario with the best
explanatory power proposes an old ancestry for PVs, a primary
radiation event that led to the generation of the different main
lineages, a second radiation of the different lineages together
with the expansion of their hosts, and a third radiation event
specific to AlphaPVs after the emergence of the E5 proto-
oncogene. We identify further a number of anomalies in the
PV tree that are inconsistent with this overall scenario. Some
of these inconsistencies can be explained by lineage sorting
and host switch events. We also show for the first time that
the E6 and E7 oncogenes may have a common ancestor,
although the alternative hypothesis of E6 and E7 from mamma-
lian PVs and from Aves/Testudines PVs having independent
origins cannot be rejected due to the still scarce sampling in
these host clades. Overall, resolution of the deep nodes and
fine support for the main scenario will require systematic
sampling of PVs from other anamniotes, from amniotes other
than mammals, from mammals other than placental mammals,
and from placental mammals other than Laurasiatherians and
Primates. We need to humbly admit that we are still far from
understanding why PV-induced cervical cancer seems to be
restricted to humans, as well as from identifying the molecular
differences between closely related viruses underlying the
enormous variance in the epidemiology of oncogenic PVs.
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